img

Global Bifidobacterium Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Bifidobacterium Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

As a kind of physiologically beneficial bacteria, bifidobacterium has many important physiological functions such as biological barrier, nutrition, anti-tumor, immune enhancement, gastrointestinal function improvement and anti-aging
The global Bifidobacterium market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Bifidobacterium is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Bifidobacterium is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Bifidobacterium is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Bifidobacterium include Valio, Chr Hansen, DSM, Yakult, Danone, Danisco, Probi, Lallemand and Nestle, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Bifidobacterium, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Bifidobacterium by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Bifidobacterium market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Bifidobacterium market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Valio
Chr Hansen
DSM
Yakult
Danone
Danisco
Probi
Lallemand
Nestle
Ganeden
By Type
Y Shape
Rod Shape
By Application
Microecological Preparation
Bifidobacterium Yogurt
Bifidobacterium Juice
Synthesis
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Bifidobacterium in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Bifidobacterium manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bifidobacterium sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Bifidobacterium Definition
1.2 Market by Type
1.2.1 Global Bifidobacterium Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Y Shape
1.2.3 Rod Shape
1.3 Market Segment by Application
1.3.1 Global Bifidobacterium Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Microecological Preparation
1.3.3 Bifidobacterium Yogurt
1.3.4 Bifidobacterium Juice
1.3.5 Synthesis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Bifidobacterium Sales
2.1 Global Bifidobacterium Revenue Estimates and Forecasts 2018-2034
2.2 Global Bifidobacterium Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Bifidobacterium Revenue by Region
2.3.1 Global Bifidobacterium Revenue by Region (2018-2024)
2.3.2 Global Bifidobacterium Revenue by Region (2024-2034)
2.4 Global Bifidobacterium Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Bifidobacterium Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Bifidobacterium Sales Quantity by Region
2.6.1 Global Bifidobacterium Sales Quantity by Region (2018-2024)
2.6.2 Global Bifidobacterium Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Bifidobacterium Sales Quantity by Manufacturers
3.1.1 Global Bifidobacterium Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Bifidobacterium Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Bifidobacterium Sales in 2022
3.2 Global Bifidobacterium Revenue by Manufacturers
3.2.1 Global Bifidobacterium Revenue by Manufacturers (2018-2024)
3.2.2 Global Bifidobacterium Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Bifidobacterium Revenue in 2022
3.3 Global Bifidobacterium Sales Price by Manufacturers
3.4 Global Key Players of Bifidobacterium, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Bifidobacterium Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Bifidobacterium, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Bifidobacterium, Product Offered and Application
3.8 Global Key Manufacturers of Bifidobacterium, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Bifidobacterium Sales Quantity by Type
4.1.1 Global Bifidobacterium Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Bifidobacterium Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Bifidobacterium Sales Quantity Market Share by Type (2018-2034)
4.2 Global Bifidobacterium Revenue by Type
4.2.1 Global Bifidobacterium Historical Revenue by Type (2018-2024)
4.2.2 Global Bifidobacterium Forecasted Revenue by Type (2024-2034)
4.2.3 Global Bifidobacterium Revenue Market Share by Type (2018-2034)
4.3 Global Bifidobacterium Price by Type
4.3.1 Global Bifidobacterium Price by Type (2018-2024)
4.3.2 Global Bifidobacterium Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Bifidobacterium Sales Quantity by Application
5.1.1 Global Bifidobacterium Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Bifidobacterium Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Bifidobacterium Sales Quantity Market Share by Application (2018-2034)
5.2 Global Bifidobacterium Revenue by Application
5.2.1 Global Bifidobacterium Historical Revenue by Application (2018-2024)
5.2.2 Global Bifidobacterium Forecasted Revenue by Application (2024-2034)
5.2.3 Global Bifidobacterium Revenue Market Share by Application (2018-2034)
5.3 Global Bifidobacterium Price by Application
5.3.1 Global Bifidobacterium Price by Application (2018-2024)
5.3.2 Global Bifidobacterium Price Forecast by Application (2024-2034)
6 North America
6.1 North America Bifidobacterium Sales by Company
6.1.1 North America Bifidobacterium Revenue by Company (2018-2024)
6.1.2 North America Bifidobacterium Sales Quantity by Company (2018-2024)
6.2 North America Bifidobacterium Market Size by Type
6.2.1 North America Bifidobacterium Sales Quantity by Type (2018-2034)
6.2.2 North America Bifidobacterium Revenue by Type (2018-2034)
6.3 North America Bifidobacterium Market Size by Application
6.3.1 North America Bifidobacterium Sales Quantity by Application (2018-2034)
6.3.2 North America Bifidobacterium Revenue by Application (2018-2034)
6.4 North America Bifidobacterium Market Size by Country
6.4.1 North America Bifidobacterium Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Bifidobacterium Revenue by Country (2018-2034)
6.4.3 North America Bifidobacterium Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Bifidobacterium Sales by Company
7.1.1 Europe Bifidobacterium Sales Quantity by Company (2018-2024)
7.1.2 Europe Bifidobacterium Revenue by Company (2018-2024)
7.2 Europe Bifidobacterium Market Size by Type
7.2.1 Europe Bifidobacterium Sales Quantity by Type (2018-2034)
7.2.2 Europe Bifidobacterium Revenue by Type (2018-2034)
7.3 Europe Bifidobacterium Market Size by Application
7.3.1 Europe Bifidobacterium Sales Quantity by Application (2018-2034)
7.3.2 Europe Bifidobacterium Revenue by Application (2018-2034)
7.4 Europe Bifidobacterium Market Size by Country
7.4.1 Europe Bifidobacterium Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Bifidobacterium Revenue by Country (2018-2034)
7.4.3 Europe Bifidobacterium Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Bifidobacterium Sales by Company
8.1.1 China Bifidobacterium Sales Quantity by Company (2018-2024)
8.1.2 China Bifidobacterium Revenue by Company (2018-2024)
8.2 China Bifidobacterium Market Size by Type
8.2.1 China Bifidobacterium Sales Quantity by Type (2018-2034)
8.2.2 China Bifidobacterium Revenue by Type (2018-2034)
8.3 China Bifidobacterium Market Size by Application
8.3.1 China Bifidobacterium Sales Quantity by Application (2018-2034)
8.3.2 China Bifidobacterium Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Bifidobacterium Sales by Company
9.1.1 APAC Bifidobacterium Sales Quantity by Company (2018-2024)
9.1.2 APAC Bifidobacterium Revenue by Company (2018-2024)
9.2 APAC Bifidobacterium Market Size by Type
9.2.1 APAC Bifidobacterium Sales Quantity by Type (2018-2034)
9.2.2 APAC Bifidobacterium Revenue by Type (2018-2034)
9.3 APAC Bifidobacterium Market Size by Application
9.3.1 APAC Bifidobacterium Sales Quantity by Application (2018-2034)
9.3.2 APAC Bifidobacterium Revenue by Application (2018-2034)
9.4 APAC Bifidobacterium Market Size by Region
9.4.1 APAC Bifidobacterium Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Bifidobacterium Revenue by Region (2018-2034)
9.4.3 APAC Bifidobacterium Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Bifidobacterium Sales by Company
10.1.1 Middle East, Africa and Latin America Bifidobacterium Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Bifidobacterium Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Bifidobacterium Market Size by Type
10.2.1 Middle East, Africa and Latin America Bifidobacterium Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Bifidobacterium Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Bifidobacterium Market Size by Application
10.3.1 Middle East, Africa and Latin America Bifidobacterium Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Bifidobacterium Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Bifidobacterium Market Size by Country
10.4.1 Middle East, Africa and Latin America Bifidobacterium Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Bifidobacterium Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Bifidobacterium Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Valio
11.1.1 Valio Company Information
11.1.2 Valio Overview
11.1.3 Valio Bifidobacterium Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Valio Bifidobacterium Products and Services
11.1.5 Valio Bifidobacterium SWOT Analysis
11.1.6 Valio Recent Developments
11.2 Chr Hansen
11.2.1 Chr Hansen Company Information
11.2.2 Chr Hansen Overview
11.2.3 Chr Hansen Bifidobacterium Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Chr Hansen Bifidobacterium Products and Services
11.2.5 Chr Hansen Bifidobacterium SWOT Analysis
11.2.6 Chr Hansen Recent Developments
11.3 DSM
11.3.1 DSM Company Information
11.3.2 DSM Overview
11.3.3 DSM Bifidobacterium Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 DSM Bifidobacterium Products and Services
11.3.5 DSM Bifidobacterium SWOT Analysis
11.3.6 DSM Recent Developments
11.4 Yakult
11.4.1 Yakult Company Information
11.4.2 Yakult Overview
11.4.3 Yakult Bifidobacterium Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Yakult Bifidobacterium Products and Services
11.4.5 Yakult Bifidobacterium SWOT Analysis
11.4.6 Yakult Recent Developments
11.5 Danone
11.5.1 Danone Company Information
11.5.2 Danone Overview
11.5.3 Danone Bifidobacterium Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Danone Bifidobacterium Products and Services
11.5.5 Danone Bifidobacterium SWOT Analysis
11.5.6 Danone Recent Developments
11.6 Danisco
11.6.1 Danisco Company Information
11.6.2 Danisco Overview
11.6.3 Danisco Bifidobacterium Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Danisco Bifidobacterium Products and Services
11.6.5 Danisco Bifidobacterium SWOT Analysis
11.6.6 Danisco Recent Developments
11.7 Probi
11.7.1 Probi Company Information
11.7.2 Probi Overview
11.7.3 Probi Bifidobacterium Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Probi Bifidobacterium Products and Services
11.7.5 Probi Bifidobacterium SWOT Analysis
11.7.6 Probi Recent Developments
11.8 Lallemand
11.8.1 Lallemand Company Information
11.8.2 Lallemand Overview
11.8.3 Lallemand Bifidobacterium Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Lallemand Bifidobacterium Products and Services
11.8.5 Lallemand Bifidobacterium SWOT Analysis
11.8.6 Lallemand Recent Developments
11.9 Nestle
11.9.1 Nestle Company Information
11.9.2 Nestle Overview
11.9.3 Nestle Bifidobacterium Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Nestle Bifidobacterium Products and Services
11.9.5 Nestle Bifidobacterium SWOT Analysis
11.9.6 Nestle Recent Developments
11.10 Ganeden
11.10.1 Ganeden Company Information
11.10.2 Ganeden Overview
11.10.3 Ganeden Bifidobacterium Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Ganeden Bifidobacterium Products and Services
11.10.5 Ganeden Bifidobacterium SWOT Analysis
11.10.6 Ganeden Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Bifidobacterium Value Chain Analysis
12.2 Bifidobacterium Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Bifidobacterium Production Mode & Process
12.4 Bifidobacterium Sales and Marketing
12.4.1 Bifidobacterium Sales Channels
12.4.2 Bifidobacterium Distributors
12.5 Bifidobacterium Customers
13 Market Dynamics
13.1 Bifidobacterium Industry Trends
13.2 Bifidobacterium Market Drivers
13.3 Bifidobacterium Market Challenges
13.4 Bifidobacterium Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Bifidobacterium Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Y Shape
Table 3. Major Manufacturers of Rod Shape
Table 4. Global Bifidobacterium Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Bifidobacterium Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Bifidobacterium Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Bifidobacterium Revenue Market Share by Region (2018-2024)
Table 8. Global Bifidobacterium Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Bifidobacterium Revenue Market Share by Region (2024-2034)
Table 10. Global Bifidobacterium Sales Quantity by Region: 2018 VS 2022 VS 2034 (MT)
Table 11. Global Bifidobacterium Sales by Region (2018-2024) & (MT)
Table 12. Global Bifidobacterium Sales Market Share by Region (2018-2024)
Table 13. Global Bifidobacterium Sales by Region (2024-2034) & (MT)
Table 14. Global Bifidobacterium Sales Market Share by Region (2024-2034)
Table 15. Global Bifidobacterium Sales Quantity by Manufacturers (2018-2024) & (MT)
Table 16. Global Bifidobacterium Sales Quantity Share by Manufacturers (2018-2024)
Table 17. Global Bifidobacterium Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Bifidobacterium Revenue Share by Manufacturers (2018-2024)
Table 19. Global Bifidobacterium Price by Manufacturers 2018-2024 (USD/Kg)
Table 20. Global Key Players of Bifidobacterium, Industry Ranking, 2021 VS 2022
Table 21. Global Bifidobacterium Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Bifidobacterium by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bifidobacterium as of 2022)
Table 23. Global Key Manufacturers of Bifidobacterium, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Bifidobacterium, Product Offered and Application
Table 25. Global Key Manufacturers of Bifidobacterium, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Bifidobacterium Sales Quantity by Type (2018-2024) & (MT)
Table 28. Global Bifidobacterium Sales Quantity by Type (2024-2034) & (MT)
Table 29. Global Bifidobacterium Sales Quantity Share by Type (2018-2024)
Table 30. Global Bifidobacterium Sales Quantity Share by Type (2024-2034)
Table 31. Global Bifidobacterium Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Bifidobacterium Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Bifidobacterium Revenue Share by Type (2018-2024)
Table 34. Global Bifidobacterium Revenue Share by Type (2024-2034)
Table 35. Bifidobacterium Price by Type (2018-2024) & (USD/Kg)
Table 36. Global Bifidobacterium Price Forecast by Type (2024-2034) & (USD/Kg)
Table 37. Global Bifidobacterium Sales Quantity by Application (2018-2024) & (MT)
Table 38. Global Bifidobacterium Sales Quantity by Application (2024-2034) & (MT)
Table 39. Global Bifidobacterium Sales Quantity Share by Application (2018-2024)
Table 40. Global Bifidobacterium Sales Quantity Share by Application (2024-2034)
Table 41. Global Bifidobacterium Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Bifidobacterium Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Bifidobacterium Revenue Share by Application (2018-2024)
Table 44. Global Bifidobacterium Revenue Share by Application (2024-2034)
Table 45. Bifidobacterium Price by Application (2018-2024) & (USD/Kg)
Table 46. Global Bifidobacterium Price Forecast by Application (2024-2034) & (USD/Kg)
Table 47. North America Bifidobacterium Revenue by Company (2018-2024) & (US$ Million)
Table 48. North America Bifidobacterium Sales Quantity by Company (2018-2024) & (MT)
Table 49. North America Bifidobacterium Sales Quantity by Type (2018-2024) & (MT)
Table 50. North America Bifidobacterium Sales Quantity by Type (2024-2034) & (MT)
Table 51. North America Bifidobacterium Revenue by Type (2018-2024) & (US$ Million)
Table 52. North America Bifidobacterium Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Bifidobacterium Sales Quantity by Application (2018-2024) & (MT)
Table 54. North America Bifidobacterium Sales Quantity by Application (2024-2034) & (MT)
Table 55. North America Bifidobacterium Revenue by Application (2018-2024) & (US$ Million)
Table 56. North America Bifidobacterium Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Bifidobacterium Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. North America Bifidobacterium Revenue by Country (2018-2024) & (US$ Million)
Table 59. North America Bifidobacterium Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Bifidobacterium Sales Quantity by Country (2018-2024) & (MT)
Table 61. North America Bifidobacterium Sales Quantity by Country (2024-2034) & (MT)
Table 62. Europe Bifidobacterium Sales Quantity by Company (2018-2024) & (MT)
Table 63. Europe Bifidobacterium Revenue by Company (2018-2024) & (US$ Million)
Table 64. Europe Bifidobacterium Sales Quantity by Type (2018-2024) & (MT)
Table 65. Europe Bifidobacterium Sales Quantity by Type (2024-2034) & (MT)
Table 66. Europe Bifidobacterium Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Bifidobacterium Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Bifidobacterium Sales Quantity by Application (2018-2024) & (MT)
Table 69. Europe Bifidobacterium Sales Quantity by Application (2024-2034) & (MT)
Table 70. Europe Bifidobacterium Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe Bifidobacterium Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Bifidobacterium Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 73. Europe Bifidobacterium Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Bifidobacterium Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Bifidobacterium Sales Quantity by Country (2018-2024) & (MT)
Table 76. Europe Bifidobacterium Sales Quantity by Country (2024-2034) & (MT)
Table 77. China Bifidobacterium Sales Quantity by Company (2018-2024) & (MT)
Table 78. China Bifidobacterium Revenue by Company (2018-2024) & (US$ Million)
Table 79. China Bifidobacterium Sales Quantity by Type (2018-2024) & (MT)
Table 80. China Bifidobacterium Sales Quantity by Type (2024-2034) & (MT)
Table 81. China Bifidobacterium Revenue by Type (2018-2024) & (US$ Million)
Table 82. China Bifidobacterium Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Bifidobacterium Sales Quantity by Application (2018-2024) & (MT)
Table 84. China Bifidobacterium Sales Quantity by Application (2024-2034) & (MT)
Table 85. China Bifidobacterium Revenue by Application (2018-2024) & (US$ Million)
Table 86. China Bifidobacterium Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Bifidobacterium Sales Quantity by Company (2018-2024) & (MT)
Table 88. APAC Bifidobacterium Revenue by Company (2018-2024) & (US$ Million)
Table 89. APAC Bifidobacterium Sales Quantity by Type (2018-2024) & (MT)
Table 90. APAC Bifidobacterium Sales Quantity by Type (2024-2034) & (MT)
Table 91. APAC Bifidobacterium Revenue by Type (2018-2024) & (US$ Million)
Table 92. APAC Bifidobacterium Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Bifidobacterium Sales Quantity by Application (2018-2024) & (MT)
Table 94. APAC Bifidobacterium Sales Quantity by Application (2024-2034) & (MT)
Table 95. APAC Bifidobacterium Revenue by Application (2018-2024) & (US$ Million)
Table 96. APAC Bifidobacterium Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Bifidobacterium Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 98. APAC Bifidobacterium Revenue by Region (2018-2024) & (US$ Million)
Table 99. APAC Bifidobacterium Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Bifidobacterium Sales Quantity by Region (2018-2024) & (MT)
Table 101. APAC Bifidobacterium Sales Quantity by Region (2024-2034) & (MT)
Table 102. Middle East, Africa and Latin America Bifidobacterium Sales Quantity by Company (2018-2024) & (MT)
Table 103. Middle East, Africa and Latin America Bifidobacterium Revenue by Company (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Bifidobacterium Sales Quantity by Type (2018-2024) & (MT)
Table 105. Middle East, Africa and Latin America Bifidobacterium Sales Quantity by Type (2024-2034) & (MT)
Table 106. Middle East, Africa and Latin America Bifidobacterium Revenue by Type (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Bifidobacterium Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Bifidobacterium Sales Quantity by Application (2018-2024) & (MT)
Table 109. Middle East, Africa and Latin America Bifidobacterium Sales Quantity by Application (2024-2034) & (MT)
Table 110. Middle East, Africa and Latin America Bifidobacterium Revenue by Application (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Bifidobacterium Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Bifidobacterium Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Bifidobacterium Revenue by Country (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Bifidobacterium Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Bifidobacterium Sales Quantity by Country (2018-2024) & (MT)
Table 116. Middle East, Africa and Latin America Bifidobacterium Sales Quantity by Country (2024-2034) & (MT)
Table 117. Valio Company Information
Table 118. Valio Description and Overview
Table 119. Valio Bifidobacterium Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 120. Valio Bifidobacterium Product and Services
Table 121. Valio Bifidobacterium SWOT Analysis
Table 122. Valio Recent Developments
Table 123. Chr Hansen Company Information
Table 124. Chr Hansen Description and Overview
Table 125. Chr Hansen Bifidobacterium Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 126. Chr Hansen Bifidobacterium Product and Services
Table 127. Chr Hansen Bifidobacterium SWOT Analysis
Table 128. Chr Hansen Recent Developments
Table 129. DSM Company Information
Table 130. DSM Description and Overview
Table 131. DSM Bifidobacterium Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 132. DSM Bifidobacterium Product and Services
Table 133. DSM Bifidobacterium SWOT Analysis
Table 134. DSM Recent Developments
Table 135. Yakult Company Information
Table 136. Yakult Description and Overview
Table 137. Yakult Bifidobacterium Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 138. Yakult Bifidobacterium Product and Services
Table 139. Yakult Bifidobacterium SWOT Analysis
Table 140. Yakult Recent Developments
Table 141. Danone Company Information
Table 142. Danone Description and Overview
Table 143. Danone Bifidobacterium Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 144. Danone Bifidobacterium Product and Services
Table 145. Danone Bifidobacterium SWOT Analysis
Table 146. Danone Recent Developments
Table 147. Danisco Company Information
Table 148. Danisco Description and Overview
Table 149. Danisco Bifidobacterium Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 150. Danisco Bifidobacterium Product and Services
Table 151. Danisco Bifidobacterium SWOT Analysis
Table 152. Danisco Recent Developments
Table 153. Probi Company Information
Table 154. Probi Description and Overview
Table 155. Probi Bifidobacterium Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 156. Probi Bifidobacterium Product and Services
Table 157. Probi Bifidobacterium SWOT Analysis
Table 158. Probi Recent Developments
Table 159. Lallemand Company Information
Table 160. Lallemand Description and Overview
Table 161. Lallemand Bifidobacterium Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 162. Lallemand Bifidobacterium Product and Services
Table 163. Lallemand Bifidobacterium SWOT Analysis
Table 164. Lallemand Recent Developments
Table 165. Nestle Company Information
Table 166. Nestle Description and Overview
Table 167. Nestle Bifidobacterium Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 168. Nestle Bifidobacterium Product and Services
Table 169. Nestle Bifidobacterium SWOT Analysis
Table 170. Nestle Recent Developments
Table 171. Ganeden Company Information
Table 172. Ganeden Description and Overview
Table 173. Ganeden Bifidobacterium Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 174. Ganeden Bifidobacterium Product and Services
Table 175. Ganeden Bifidobacterium SWOT Analysis
Table 176. Ganeden Recent Developments
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Bifidobacterium Distributors List
Table 180. Bifidobacterium Customers List
Table 181. Bifidobacterium Market Trends
Table 182. Bifidobacterium Market Drivers
Table 183. Bifidobacterium Market Challenges
Table 184. Bifidobacterium Market Restraints
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Bifidobacterium Product Picture
Figure 2. Global Bifidobacterium Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Bifidobacterium Market Share by Type in 2022 & 2034
Figure 4. Y Shape Product Picture
Figure 5. Rod Shape Product Picture
Figure 6. Global Bifidobacterium Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Bifidobacterium Market Share by Application in 2022 & 2034
Figure 8. Microecological Preparation
Figure 9. Bifidobacterium Yogurt
Figure 10. Bifidobacterium Juice
Figure 11. Synthesis
Figure 12. Bifidobacterium Report Years Considered
Figure 13. Global Bifidobacterium Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Bifidobacterium Revenue 2018-2034 (US$ Million)
Figure 15. Global Bifidobacterium Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 16. Global Bifidobacterium Sales Quantity 2018-2034 (MT)
Figure 17. Global Bifidobacterium Sales Quantity Market Share by Region (2018-2024)
Figure 18. Global Bifidobacterium Sales Quantity Market Share by Region (2024-2034)
Figure 19. North America Bifidobacterium Sales Quantity YoY (2018-2034) & (MT)
Figure 20. North America Bifidobacterium Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Bifidobacterium Sales Quantity YoY (2018-2034) & (MT)
Figure 22. Europe Bifidobacterium Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Bifidobacterium Sales Quantity YoY (2018-2034) & (MT)
Figure 24. China Bifidobacterium Revenue YoY (2018-2034) & (US$ Million)
Figure 25. APAC Bifidobacterium Sales Quantity YoY (2018-2034) & (MT)
Figure 26. APAC Bifidobacterium Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Bifidobacterium Sales Quantity YoY (2018-2034) & (MT)
Figure 28. Middle East, Africa and Latin America Bifidobacterium Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Bifidobacterium Sales Quantity in 2022
Figure 30. The Top 10 and Top 5 Players Market Share by Bifidobacterium Revenue in 2022
Figure 31. Bifidobacterium Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Bifidobacterium Sales Quantity Market Share by Type (2018-2034)
Figure 33. Global Bifidobacterium Revenue Market Share by Type (2018-2034)
Figure 34. Global Bifidobacterium Sales Quantity Market Share by Application (2018-2034)
Figure 35. Global Bifidobacterium Revenue Market Share by Application (2018-2034)
Figure 36. North America Bifidobacterium Revenue Market Share by Company in 2022
Figure 37. North America Bifidobacterium Sales Quantity Market Share by Company in 2022
Figure 38. North America Bifidobacterium Sales Quantity Market Share by Type (2018-2034)
Figure 39. North America Bifidobacterium Revenue Market Share by Type (2018-2034)
Figure 40. North America Bifidobacterium Sales Quantity Market Share by Application (2018-2034)
Figure 41. North America Bifidobacterium Revenue Market Share by Application (2018-2034)
Figure 42. North America Bifidobacterium Revenue Share by Country (2018-2034)
Figure 43. North America Bifidobacterium Sales Quantity Share by Country (2018-2034)
Figure 44. U.S. Bifidobacterium Revenue (2018-2034) & (US$ Million)
Figure 45. Canada Bifidobacterium Revenue (2018-2034) & (US$ Million)
Figure 46. Europe Bifidobacterium Sales Quantity Market Share by Company in 2022
Figure 47. Europe Bifidobacterium Revenue Market Share by Company in 2022
Figure 48. Europe Bifidobacterium Sales Quantity Market Share by Type (2018-2034)
Figure 49. Europe Bifidobacterium Revenue Market Share by Type (2018-2034)
Figure 50. Europe Bifidobacterium Sales Quantity Market Share by Application (2018-2034)
Figure 51. Europe Bifidobacterium Revenue Market Share by Application (2018-2034)
Figure 52. Europe Bifidobacterium Revenue Share by Country (2018-2034)
Figure 53. Europe Bifidobacterium Sales Quantity Share by Country (2018-2034)
Figure 54. Germany Bifidobacterium Revenue (2018-2034) & (US$ Million)
Figure 55. France Bifidobacterium Revenue (2018-2034) & (US$ Million)
Figure 56. U.K. Bifidobacterium Revenue (2018-2034) & (US$ Million)
Figure 57. Italy Bifidobacterium Revenue (2018-2034) & (US$ Million)
Figure 58. Russia Bifidobacterium Revenue (2018-2034) & (US$ Million)
Figure 59. China Bifidobacterium Sales Quantity Market Share by Company in 2022
Figure 60. China Bifidobacterium Revenue Market Share by Company in 2022
Figure 61. China Bifidobacterium Sales Quantity Market Share by Type (2018-2034)
Figure 62. China Bifidobacterium Revenue Market Share by Type (2018-2034)
Figure 63. China Bifidobacterium Sales Quantity Market Share by Application (2018-2034)
Figure 64. China Bifidobacterium Revenue Market Share by Application (2018-2034)
Figure 65. APAC Bifidobacterium Sales Quantity Market Share by Company in 2022
Figure 66. APAC Bifidobacterium Revenue Market Share by Company in 2022
Figure 67. APAC Bifidobacterium Sales Quantity Market Share by Type (2018-2034)
Figure 68. APAC Bifidobacterium Revenue Market Share by Type (2018-2034)
Figure 69. APAC Bifidobacterium Sales Quantity Market Share by Application (2018-2034)
Figure 70. APAC Bifidobacterium Revenue Market Share by Application (2018-2034)
Figure 71. APAC Bifidobacterium Revenue Share by Region (2018-2034)
Figure 72. APAC Bifidobacterium Sales Quantity Share by Region (2018-2034)
Figure 73. Japan Bifidobacterium Revenue (2018-2034) & (US$ Million)
Figure 74. South Korea Bifidobacterium Revenue (2018-2034) & (US$ Million)
Figure 75. China Taiwan Bifidobacterium Revenue (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Bifidobacterium Revenue (2018-2034) & (US$ Million)
Figure 77. India Bifidobacterium Revenue (2018-2034) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Bifidobacterium Sales Quantity Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America Bifidobacterium Revenue Market Share by Company in 2022
Figure 80. Middle East, Africa and Latin America Bifidobacterium Sales Quantity Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Bifidobacterium Revenue Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Bifidobacterium Sales Quantity Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Bifidobacterium Revenue Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Bifidobacterium Sales Quantity Share by Country (2018-2034)
Figure 85. Middle East, Africa and Latin America Bifidobacterium Revenue Share by Country (2018-2034)
Figure 86. Brazil Bifidobacterium Revenue (2018-2034) & (US$ Million)
Figure 87. Mexico Bifidobacterium Revenue (2018-2034) & (US$ Million)
Figure 88. Turkey Bifidobacterium Revenue (2018-2034) & (US$ Million)
Figure 89. Israel Bifidobacterium Revenue (2018-2034) & (US$ Million)
Figure 90. GCC Countries Bifidobacterium Revenue (2018-2034) & (US$ Million)
Figure 91. Bifidobacterium Value Chain
Figure 92. Bifidobacterium Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed